PRODUCTS PORFOLIO & LAI OPPORTUNITIES LATEST NEWS PHASE 3 DATA OF MDC-IRM FIRST PRODUCT BASED ON MEDINCELL’S TECHNOLOGY, SHOWS SIGNIFICANT IMPROVEMENTS IN PATIENTS WITH SCHIZOPHRENIA As of December, 2020 FAVORABLE RISK ASSESSMENT All current products under development are based on already approved APIs. When compared to NCEs (New Chemical Entity), use of well-understood, approved APIs is an opportunity to make treatments quickly available with significantly less financial resources needed and less risk in clinical phases. LAI Opportunities Identification We have designed a structured approach to identify LAI opportunities and enlarge our portfolio of proprietary and partnered products. This assessment process aims to identify the unmet needs in a large panel of indications that could be met with LAI and to identify the most compatible APIs with our technology. This preliminary step is essential to significantly increase the likelihood of success for each product entering formulation stage. Opportunities with approved APIs Products based on already approved APIs can benefit from decreased time-to-market thanks to simplified pathways such as the 505(b)2 in the US, while providing all of the benefits from long-acting formulations with controlled release. Opportunities with new APIs There is a significant number of new therapeutic molecules that could be optimized for long-acting injectable treatments. Our technology could be the empowering entity to APIs that can’t be used in today’s traditional, drug delivery systems, or whose benefits would be limited as a result of toxicity. We’re always looking for new talent See our career opportunities Subject Partnership Development Scientific collaboration Press and communication Administration People Stay tuned, leave your email I read and accept the privacy policy HOME WHO ARE WE PRODUCT IMPACT NETWORK NEWS INVESTORS CAREERS Copyright © 2021 MedinCell. All rights reserved. | Legal | Privacy | #BetterMedicineForAll | #ImpactHealth | WHO ARE WE PRODUCT IMPACT NETWORK NEWS INVESTORS CAREERS